These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 9878638

  • 1. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G.
    N Engl J Med; 1999 Jan 07; 340(1):1-8. PubMed ID: 9878638
    [Abstract] [Full Text] [Related]

  • 2. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R.
    Crit Care Med; 2006 Mar 07; 34(3):668-75. PubMed ID: 16505651
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial-impregnated central venous catheters.
    Paterson DL.
    N Engl J Med; 1999 Jun 03; 340(22):1761; author reply 1762. PubMed ID: 10357631
    [No Abstract] [Full Text] [Related]

  • 4. Antimicrobial-impregnated central venous catheters.
    Maury E, Offenstadt G.
    N Engl J Med; 1999 Jun 03; 340(22):1761-2; author reply 1762. PubMed ID: 10357632
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
    Osma S, Kahveci SF, Kaya FN, Akalin H, Ozakin C, Yilmaz E, Kutlay O.
    J Hosp Infect; 2006 Feb 03; 62(2):156-62. PubMed ID: 16307824
    [Abstract] [Full Text] [Related]

  • 6. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P, de Vaumas C, Samba D, Boulet E, Lefrant JY, Eyraud D, Lherm T, Santoli F, Naija W, Riou B.
    Crit Care Med; 2007 Apr 03; 35(4):1032-9. PubMed ID: 17334256
    [Abstract] [Full Text] [Related]

  • 7. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
    Hanna H, Benjamin R, Chatzinikolaou I, Alakech B, Richardson D, Mansfield P, Dvorak T, Munsell MF, Darouiche R, Kantarjian H, Raad I.
    J Clin Oncol; 2004 Aug 01; 22(15):3163-71. PubMed ID: 15284269
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, Koulourida V, Georgopoulos D, Gerogianni N, Nakos G, Matamis D, Catheter-Related Infections in ICU (CRI-ICU) Group.
    Crit Care Med; 2012 Feb 01; 40(2):420-9. PubMed ID: 21926583
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S, Mazuski JE, Sona C, Schallom M, Boyle W, Buchman TG, Bochicchio GV, Coopersmith CM, Schuerer DJ.
    J Am Coll Surg; 2015 Sep 01; 221(3):739-47. PubMed ID: 26199017
    [Abstract] [Full Text] [Related]

  • 10. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K, Zenz S, Jüttner B, Ruschulte H, Kuse E, Heine J, Piepenbrock S, Ganser A, Karthaus M.
    Ann Hematol; 2005 Apr 01; 84(4):258-62. PubMed ID: 15549302
    [Abstract] [Full Text] [Related]

  • 11. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria.
    Yorganci K, Krepel C, Weigelt JA, Edmiston CE.
    Eur J Clin Microbiol Infect Dis; 2002 May 01; 21(5):379-84. PubMed ID: 12072923
    [Abstract] [Full Text] [Related]

  • 12. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ, Zack JE, Thomas J, Borecki IB, Sona CS, Schallom ME, Venker M, Nemeth JL, Ward MR, Verjan L, Warren DK, Fraser VJ, Mazuski JE, Boyle WA, Buchman TG, Coopersmith CM.
    Surg Infect (Larchmt); 2007 Aug 01; 8(4):445-54. PubMed ID: 17883361
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
    Maaskant JM, De Boer JP, Dalesio O, Holtkamp MJ, Lucas C.
    Eur J Cancer Care (Engl); 2009 Sep 01; 18(5):477-82. PubMed ID: 19453696
    [Abstract] [Full Text] [Related]

  • 14. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
    Camargo LF, Marra AR, Büchele GL, Sogayar AM, Cal RG, de Sousa JM, Silva E, Knobel E, Edmond MB.
    J Hosp Infect; 2009 Jul 01; 72(3):227-33. PubMed ID: 19443078
    [Abstract] [Full Text] [Related]

  • 15. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
    Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I.
    J Antimicrob Chemother; 2007 Mar 01; 59(3):359-69. PubMed ID: 17255143
    [Abstract] [Full Text] [Related]

  • 16. The evolving technology of venous access.
    Wenzel RP, Edmond MB.
    N Engl J Med; 1999 Jan 07; 340(1):48-50. PubMed ID: 9878645
    [No Abstract] [Full Text] [Related]

  • 17. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keating K, Civetta JM, Mermel LA, Lee D, Dellinger EP, Donahoe M, Giles D, Pfaller MA, Maki DG, Sherertz R.
    Ann Intern Med; 2005 Oct 18; 143(8):570-80. PubMed ID: 16230723
    [Abstract] [Full Text] [Related]

  • 18. Central venous catheterization: a prospective, randomized, double-blind study.
    Mer M, Duse AG, Galpin JS, Richards GA.
    Clin Appl Thromb Hemost; 2009 Feb 18; 15(1):19-26. PubMed ID: 18593746
    [Abstract] [Full Text] [Related]

  • 19. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis.
    Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ.
    Am Surg; 1996 Aug 18; 62(8):641-6. PubMed ID: 8712561
    [Abstract] [Full Text] [Related]

  • 20. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.
    León C, Alvarez-Lerma F, Ruiz-Santana S, González V, de la Torre MV, Sierra R, León M, Rodrigo JJ.
    Crit Care Med; 2003 May 18; 31(5):1318-24. PubMed ID: 12771597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.